Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Interventional Radiology(Electronic Edition) ›› 2022, Vol. 10 ›› Issue (01): 75-82. doi: 10.3877/cma.j.issn.2095-5782.2022.01.014

• Review • Previous Articles     Next Articles

Research status and progress of microRNA in cerebral ischemia-reperfusion injury

Zheyu Jiang1, Tianpeng Jiang1, Shi Zhou1, Lizhou Wang1,()   

  1. 1. Department of Interventional Radiology and Vascular Surgery, Affiliated Hospital of Guizhou Medical University, Guizhou Guiyang 550004, China
  • Received:2021-04-06 Online:2022-02-25 Published:2022-03-23
  • Contact: Lizhou Wang

Abstract:

Ischemic stroke is one of the leading cause of death and disability in adults. Vascular recanalization to obtain timely reperfusion is the preferred treatment in clinical practice. However, reperfusion can induce cerebral ischemia-reperfusion injury (CIRI). The present research reveal that microRNAs (miRs) have been implicated in CIRI and could serve as therapeutic targets. As a research hotspot, the abnormal expression and function of miRs have been receiving more and more attention. Although relevant studies have suggested the safety and effectiveness of regulating miRs in the treatment of CIRI, there are no randomized controlled trials to formulate uniform standard guideline. This article aims to make a comprehensive review about the current status and progress of the research on the signaling pathways, pathological mechanisms, and various interactions of miRs involved in CIRI.

Key words: Cerebral ischemia-reperfusion injury, MicroRNAs, Therapeutic targets

京ICP 备07035254号-20
Copyright © Chinese Journal of Interventional Radiology(Electronic Edition), All Rights Reserved.
Tel: 0756-2528259 E-mail: zhjrfsx@163.com
Powered by Beijing Magtech Co. Ltd